Mineralys Therapeutics, Inc. (MLYS) Stock: News, Analysis, Q&A, and Insights

Investment Analysis Report: MLYS

Overview:

MLYS is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $636,307,226. In this report, we will conduct a comprehensive analysis of MLYS focusing on various perspectives including Valuation, Financial Health, Earni...

Technical Analysis of MLYS 2024-05-10

Overview:

In analyzing the technical indicators for MLYS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide your invest...

Recent News & Updates

2024-05-13 11:45
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript(Insider Monkey)
2024-05-13 08:08
We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth(Simply Wall St.)
2024-05-09 07:00
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update(GlobeNewswire)
2024-05-08 23:56
MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024(Investorplace)
2024-05-08 19:00
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-05-06 08:00
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference(GlobeNewswire)
2024-05-05 20:00
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference(Globenewswire)
2024-05-02 08:00
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024(GlobeNewswire)
2024-05-01 20:00
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024(Globenewswire)
2024-04-05 00:16
Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks(TipRanks)
2024-03-22 10:51
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript(Insider Monkey)
2024-03-21 09:11
Mineralys Therapeutics Inc (MLYS) Reports Increased R&D Expenses Amid Progress in ...(GuruFocus.com)
2024-03-21 07:00
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update(GlobeNewswire)
2024-03-20 23:53
MLYS Stock Earnings: Mineralys Therapeutics Beats EPS for Q4 2023(Investorplace)
2024-03-20 19:00
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update(Globenewswire)
2024-03-13 16:05
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024(GlobeNewswire)
2024-03-13 04:05
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024(Globenewswire)
2024-02-08 08:00
Mineralys Therapeutics Announces $120 Million Private Placement Financing(GlobeNewswire)
2024-02-07 19:00
Mineralys Therapeutics Announces $120 Million Private Placement Financing(Globenewswire)
2024-01-29 16:05
Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference(GlobeNewswire)
2024-01-29 03:05
Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference(Globenewswire)
2024-01-17 12:00
Mineralys Therapeutics, Inc. (MLYS) Upgraded to Strong Buy: Here's What You Should Know(Zacks)
2024-01-16 23:00
Mineralys Therapeutics, Inc. (MLYS) Upgraded to Strong Buy: Here's What You Should Know(Zacks)
2024-01-04 16:05
Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer(GlobeNewswire)
2024-01-04 03:05
Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer(Globenewswire)
2023-12-21 16:05
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension(GlobeNewswire)
2023-12-21 03:05
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension(Globenewswire)
2023-11-27 08:12
Positive Signs As Multiple Insiders Buy Mineralys Therapeutics Stock(Simply Wall St.)
2023-11-12 09:22
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q3 2023 Earnings Call Transcript(Insider Monkey)
2023-11-11 11:30
Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023(GlobeNewswire)

Page 1 of 3

previousnext

Home

Market Lens

Ideas Explorer

History

Recent Activity

MLYS

Performance

Profile

Investment Analysis Report: MLYS

Overview:

Technical Analysis of MLYS 2024-05-10

Overview:

Recent News & Updates